Liver Enzyme Elevation in Patients Taking Depression/Anxiety and Dementia Medications

Antidepressants and Hepatotoxicity Risk

• The American Academy of Family Physicians notes that antidepressants can cause asymptomatic aminotransferase elevation in 0.5-3% of patients, with nefazodone requiring monitoring for hepatotoxicity and dose reduction or discontinuation if significant enzyme elevation occurs 2

Dementia Medications and Liver Enzymes

• The American Academy of Family Physicians recommends that donepezil, rivastigmine, and galantamine are safe choices for dementia medications with minimal hepatotoxic concerns, while tacrine causes elevation of liver enzyme levels in 40% of treated patients and requires biweekly liver tests during dosage escalations and every three months thereafter 1
• Tacrine should be considered a second-line agent due to its hepatotoxic profile, and its use requires regular monitoring of liver enzymes 1

Clinical Management Approach

• If aminotransferases increase to ≥3 times ULN, consider holding the medication and repeating liver function tests within 48-72 hours, as recommended by Praxis Medical Insights 3
• For medications like cariprazine, baseline liver function tests should be obtained with regular monitoring, particularly in the first few weeks of treatment, as recommended by Praxis Medical Insights 4